Drug Shortage Report for SOFRACORT

Last updated on 2023-12-01 History
Report ID 202983
Drug Identification Number 02224623
Brand name SOFRACORT
Common or Proper name Framycetin sulphate, Dexamethasone and Gramicidin Ophthalmic/Otic Solution
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) GRAMICIDIN DEXAMETHASONE FRAMYCETIN SULFATE
Strength(s) 0.05MG 0.5MG 5MG
Dosage form(s) DROPS
Route of administration OTIC OPHTHALMIC OTIC OPHTHALMIC
Packaging size 8 mL bottle
ATC code S03CA
ATC description CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-08-28
Actual start date 2023-08-28
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2023-12-01
Company comments Requirements related to complying with good manufacturing practices.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-12-01 French Compare
v6 2023-12-01 English Compare
v5 2023-10-02 French Compare
v4 2023-10-02 English Compare
v3 2023-08-29 English Compare
v2 2023-08-25 French Compare
v1 2023-08-25 English Compare

Showing 1 to 7 of 7